Zealand Pharma Announces Full Year Results And Publication Of The Annual Report For 2013

Published: Mar 20, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Copenhagen, 20 March 2014 – Zealand Pharma A/S (“Zealand”) (NASDAQ OMX Copenhagen: ZEAL), announces financial results in line with guidance and important advances for the company’s portfolio of peptide based medicines, including the launch of Lyxumia®, for the twelve month period from 1 January to 31 December 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news